DEUTSCHE BANK AG\

Bank

Position in PBYI — Puma Biotechnology, Inc.

CIK 948046 FRANKFURT AM MAIN, 2M

Position in PBYI

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$211,796

+$48,551 QoQ

Shares Held

33,145

+7.8% QoQ

Ownership

0.065%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

DEUTSCHE BANK AG\ holds $2,920,327,422 across 248 Biotechnology names. PBYI ranks #191 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,537,736	$686,660,626
2	REGN	Regeneron Pharmaceuticals, Inc.	625,388	$483,199,777
3	ALNY	Alnylam Pharmaceuticals, Inc.	761,464	$251,945,590
4	INCY	Incyte Corp	1,264,195	$118,986,027
5	RPRX	Royalty Pharma plc	2,453,303	$117,684,942
6	ARGX	Argenx SE	139,381	$101,782,972
7	INSM	INSMED Inc	562,474	$91,975,745
8	LGND	Ligand Pharmaceuticals Inc	306,111	$61,115,059

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$211,796	33,145	+7.8%	Shares	Defined	2026-05-06
2025-09-30	$163,245	30,743	0.0%	Shares	Defined	2025-11-13
2025-06-30	$105,448	30,743	0.0%	Shares	Defined	2025-08-12
2025-03-31	$90,999	30,743	+66.4%	Shares	Defined	2025-05-09
2022-03-31	$53,210	18,476	-10.1%	Shares	Defined	2022-05-13
2021-12-31	$62,483	20,554	-0.3%	Shares	Defined	2022-02-16
2021-09-30	$144,488	20,612	-37.6%	Shares	Defined	2021-11-04
2021-06-30	$303,425	33,053	+26.2%	Shares	Defined	2021-08-11
2021-03-31	$254,488	26,182	-6.7%	Shares	Defined	2021-05-13
2020-12-31	$287,842	28,055	-92.5%	Shares	Defined	2021-02-16
2020-09-30	$3,756,071	372,257	-42.1%	Shares	Defined	2020-11-12
2020-06-30	$6,710,003	643,337	+17.8%	Shares	Defined	2020-08-13
2020-03-31	$4,608,728	546,058	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.